Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 100 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $241,000 | -33.4% | 16,720 | -30.1% | 0.09% | -27.6% |
| Q2 2022 | $362,000 | +19.9% | 23,910 | -6.1% | 0.13% | +35.1% |
| Q1 2022 | $302,000 | +2.0% | 25,450 | +39.6% | 0.09% | +22.1% |
| Q4 2021 | $296,000 | -24.7% | 18,230 | +32.5% | 0.08% | -28.0% |
| Q3 2021 | $393,000 | -12.5% | 13,760 | +3.5% | 0.11% | -15.7% |
| Q2 2021 | $449,000 | +20.1% | 13,290 | +7.4% | 0.13% | +10.4% |
| Q1 2021 | $374,000 | -30.0% | 12,380 | +14.8% | 0.12% | -31.5% |
| Q4 2020 | $534,000 | +40.5% | 10,780 | +9.0% | 0.17% | +20.9% |
| Q3 2020 | $380,000 | -5.2% | 9,890 | +6.5% | 0.14% | -12.6% |
| Q2 2020 | $401,000 | – | 9,290 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $2,271,000 | 2.63% |
| Sofinnova Investments, Inc. | 2,194,278 | $26,068,000 | 1.98% |
| MPM BioImpact LLC | 443,702 | $5,271,000 | 1.42% |
| Soleus Capital Management, L.P. | 238,982 | $2,839,000 | 0.37% |
| Lombard Odier Asset Management (Switzerland) SA | 221,774 | $2,635,000 | 0.21% |
| Artal Group S.A. | 400,000 | $4,752,000 | 0.20% |
| Polar Capital Holdings Plc | 2,877,671 | $34,187,000 | 0.15% |
| ASHFORD CAPITAL MANAGEMENT INC | 106,770 | $1,268,000 | 0.14% |
| Cormorant Asset Management, LP | 150,000 | $1,782,000 | 0.14% |
| Virtus ETF Advisers LLC | 23,646 | $281,000 | 0.13% |